Avril J. Vermunt

Avril loves contributing her 20+ years of experience towards biopharmaceutical manufacturing innovation to enable compliant operations and improve patient accessibility & affordability. Her previous experiences include leadership positions at EQRx and Adverum Bio, technology strategy and management roles at Cytiva, process development at Amgen, and manufacturing at Fujifilm Diosynth.

She has been an ISPE member since joining the student chapter at North Carolina State University, where she received her degree in Chemical Engineering. She also completed the Executive MBA program at the University of Colorado and is in progress in the Doctorate of Engineering program at Pennsylvania State University.

Related Articles

Article
Technical
Inline Dilution: An Agile Capability for Downstream Manufacturing

As the global population demands faster and more affordable drugs, biopharmaceutical companies are continually trying to find ways to produce their drug products more economically and efficiently. Today, the competition and need for drugs are greater than ever before. Companies have been considering operational alternatives to reduce production costs and increase manufacturing rates.